This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Manning, R. D. Articles by Granger, J. P. Search for Related Content PubMed PubMed Citation Articles by Manning, R. D., Jr Articles by Granger, J. P.

Hypertension, Vol 21, 949-955, Copyright © 1993 by American Heart Association

ARTICLES

Role of nitric oxide in long-term angiotensin II-induced renal vasoconstriction

RD Manning Jr, L Hu, HL Mizelle and JP Granger
Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson 39216-4505.

In vitro studies have indicated that nitric oxide may play an important role in modulating the renal vascular actions of angiotensin II (Ang II). However, the physiological importance of this interaction in the long-term regulation of renal hemodynamics is unknown. Therefore, the goal of this study was to determine if long-term Ang II-induced renal vasoconstriction was potentiated by nitric oxide synthesis inhibition. The intrarenal effects of Ang II were examined in eight unilaterally nephrectomized, conscious dogs before and after systemic inhibition of nitric oxide synthesis. Ang II infusion into the renal artery at 0.5 ng/kg per minute resulted in decreases in renal plasma flow of 15% and 9% after 3 and 5 days, respectively. During this time, glomerular filtration rate decreased 12% after 3 days of angiotensin but was not significantly changed after 5 days. After 4 days of recovery from Ang II, nitric oxide synthesis was inhibited with intravenous NG-nitro-L- arginine-methyl ester (L-NAME) at 10 micrograms/kg per minute for 5 days, and this caused a significant decrease in renal plasma flow but no change in glomerular filtration rate. Infusion of Ang II into L-NAME- pretreated dogs for an additional 5 days further decreased renal plasma flow and glomerular filtration 14% and 11%, respectively. However, the effects of Ang II and L-NAME on renal plasma flow were only additive on days 3 and 5 of this period, and the effects on glomerular filtration were additive on day 3 but were potentiated on day 5.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				H. Berthold, A. Just, H. R. Kirchheim, and H. Ehmke Interaction Between Nitric Oxide and Endogenous Vasoconstrictors in Control of Renal Blood Flow Hypertension, December 1, 1999; 34(6): 1254 - 1258. [Abstract] [Full Text] [PDF]

				J. P. Granger, S. Kassab, J. Novak, J. F. Reckelhoff, B. Tucker, and M. T. Miller Role of nitric oxide in modulating renal function and arterial pressure during chronic aldosterone excess Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R197 - R202. [Abstract] [Full Text] [PDF]

				J. Granger, C. Schnackenberg, J. Novak, B. Tucker, T. Miller, S. Morgan, and S. Kassab Role of Nitric Oxide in Modulating the Long-term Renal and Hypertensive Actions of Norepinephrine Hypertension, January 1, 1997; 29(1): 205 - 209. [Abstract] [Full Text] [PDF]

				X. Deng, W. J. Welch, and C. S. Wilcox Role of Nitric Oxide in Short-term and Prolonged Effects of Angiotensin II on Renal Hemodynamics Hypertension, May 1, 1996; 27(5): 1173 - 1179. [Abstract] [Full Text]

				J. Granger, J. Novak, C. Schnackenberg, S. Williams, and G. A. Reinhart Role of Renal Nerves in Mediating the Hypertensive Effects of Nitric Oxide Synthesis Inhibition Hypertension, March 1, 1996; 27(3): 613 - 618. [Abstract] [Full Text]